GOODRX HOLDINGS INC-CLASS A (GDRX) Stock News
NASDAQ:GDRX - Nasdaq - US38246G1085 - Common Stock - Currency: USD
GDRX Latest News, Press Relases and Analysis
KeyBanc Maintains Overweight Rating on GoodRx (GDRX)
GoodRx Holdings, Inc. (NASDAQ:GDRX) is one of the 11 Best US Stocks to Invest in Under $5. On May 14, KeyBanc Capital Markets reiterated an “Overweight” rating on GoodRx Holdings, Inc. (NASDAQ:GDRX) with a price target of $6. KeyBanc’s analyst, Scott Schoenhaus, highlighted the current position of GoodRx Holdings, Inc. (NASDAQ:GDRX) within the challenging retail […]
Should You Buy Ford While It's Below $11?
Thanks to Ford's employee pricing program, unit sales have grown by double digits in the past three months. As a mass-market automaker, Ford’s operations require huge amounts of capital, with returns that aren't impressive. For the past 48 consecutive years, Ford (NYSE: F) has sold America's most popular passenger vehicle line.
GDRX vs. PGNY: Which Stock Should Value Investors Buy Now?
GDRX vs. PGNY: Which Stock Is the Better Value Option?
Mentions: PGNY
Berenberg Bank Maintains a Hold Rating on Novartis (NVS)
Novartis AG (NYSE:NVS) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. On June 12, Berenberg Bank analyst Luisa Hector maintained a Hold rating on Novartis AG (NYSE:NVS) and set a price target of CHF89.00. The same day, the company reported statistically significant improvements in the Phase IIIB APPULSE-PNH study. […]
Covius Services to Acquire Blend Labs’ (BLND) Title365 Holding Co
Blend Labs, Inc. (NYSE:BLND) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June 9, Blend Labs, Inc. (NYSE:BLND) announced signing a definitive agreement with Covius Services to sell its Title365 Holding Co. Title365 is a national title insurance and settlement services company licensed in 43 states. It serves top lenders, servicers, […]
Raymond James Resumes Coverage on Disc Medicine (IRON) With a Strong Buy Rating
Disc Medicine, Inc. (NASDAQ:IRON) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June 11, analysts from Raymond James resumed coverage of Disc Medicine, Inc. (NASDAQ:IRON) with a strong Buy rating and a price target of $89. The resumed coverage comes as the company released its research note on Biotech names. […]
GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing
Jim Cramer Holds Back on GoodRx (GDRX)
We recently published a list of Jim Cramer’s Thoughts on These 12 Stocks. In this article, we are going to take a look at where GoodRx Holdings, Inc. (NASDAQ:GDRX) stands against other stocks that Jim Cramer discusses. Noting that Cramer has not said anything about GoodRx Holdings, Inc. (NASDAQ:GDRX) in a long time, a caller […]
Jim Cramer Says “Fluor (FLR)’s Always a Bridesmaid, Never a Bride”
We recently published a list of Jim Cramer’s Thoughts on These 12 Stocks. In this article, we are going to take a look at where Fluor Corporation (NYSE:FLR) stands against other stocks that Jim Cramer discusses. Answering a caller’s query about Fluor Corporation (NYSE:FLR) during the lightning round, Cramer remarked: “Fluor’s always a bridesmaid, never […]
Jim Cramer Says to “Buy Dover (DOV) Right Now”
We recently published a list of Jim Cramer’s Thoughts on These 12 Stocks. In this article, we are going to take a look at where Dover Corporation (NYSE:DOV) stands against other stocks that Jim Cramer discusses. Inquiring about Dover Corporation (NYSE:DOV), a caller asked if Cramer thinks that the stock will ever hit $222. He […]
Jim Cramer on GE Aerospace (GE): “I Truly Love GE Aerospace Right Here”
We recently published a list of Jim Cramer’s Thoughts on These 12 Stocks. In this article, we are going to take a look at where GE Aerospace (NYSE:GE) stands against other stocks that Jim Cramer discusses. A caller inquired about GE Aerospace (NYSE:GE) during the episode. Cramer replied that he loves the stock here. “GE […]
Jim Cramer Notes GE Vernova (GEV) Knows “How to Build Nuclear Plants”
We recently published a list of Jim Cramer’s Thoughts on These 12 Stocks. In this article, we are going to take a look at where GE Vernova (NYSE:GEV) stands against other stocks that Jim Cramer discusses. During the episode, Cramer showed optimism around GE Vernova Inc.’s (NYSE:GEV) capability around building nuclear plants, as he said: […]
Jim Cramer on Netflix, Inc. (NFLX): “May Be Still the Best Growing Stock in the Entire Market”
We recently published a list of Jim Cramer Talked About These 16 Stocks Recently. In this article, we are going to take a look at where Netflix, Inc. (NASDAQ:NFLX) stands against other stocks that Jim Cramer discussed recently. Noting that the stock has been going “up and up”, a caller inquired about Netflix, Inc. (NASDAQ:NFLX). […]
GoodRx to Launch Direct Contracting for Independent Community Pharmacies
Morgan Stanley Raises The Progressive Corporation (PGR)’s Price Target to $330 from $320, Maintains Overweight Rating
On May 19, Morgan Stanley analyst Bob Huang raised The Progressive Corporation (NYSE:PGR)’s price target to $330 per share, representing a 3.12% increase from the prior target price of $320. The raise reflects the analysts’ strong confidence in the company’s future performance. The stock has surged 20% year-to-date, comfortably outpacing the broader market index, which […]
UBS Upgrades Archer Daniels (ADM) Stock to Buy, Lifts PT
On May 19, UBS analyst Manav Gupta upped Archer-Daniels-Midland Company (NYSE:ADM)’s stock from “Neutral” to “Buy,” raising the price objective to $60 from the prior target of $55. The analyst highlighted the potential policy benefits, together with an optimistic outlook for its nutrition segment, as critical drivers. The House’s budget reconciliation bill has made it […]
GoodRx Offers Value Proposition As Pharmacy Costs Shifts To Consumers: Analyst
JP Morgan analyst Lisa C. Gill revised her 2025 outlook on GoodRx Holdings (NASDAQ:GDRX) following the company’s first-quarter earnings. Gill reaffirmed an Overweight rating on the stock and maintained her $7 price forecast. The company reported first-quarter 2025 revenue of $203 million (above the $202.21 million estimate), up 3% year-over-year. Adjusted EBITDA rose to $69.8 million, with margins improving to 34.4% from 31.7%. Net income came in at $11.1 million, reversing a $1 million loss in
GoodRx Offers Value Proposition As Pharmacy Costs Shifts To Consumers: Analyst
J.P. Morgan analyst revises outlook on GoodRx Holdings following Q1 earnings, reaffirms Overweight rating and $7 price target.
Mentions: JPM
The Zacks Analyst Blog Highlights Sprouts Farmers Market, DexCom, Hims & Hers Health, United Natural Foods and GoodRx
Sprouts Farmers Market, DexCom, Hims & Hers Health, United Natural Foods and GoodRx are included in this Analyst Blog.
Buy 5 Health and Fitness Stocks to Enhance Your Portfolio Returns
Five Health and Fitness stocks to buy now are: SFM, DXCM, HIMS, UNFI, GDRX.
Nissan abandons plan for $1.1 billion EV battery plant in southern Japan
TOKYO (Reuters) -Nissan Motor said on Friday it would abandon a plan to build a $1.1 billion factory for electric vehicle batteries on Japan's southwestern island of Kyushu, marking the latest change of plans for the troubled automaker. The company is also preparing to offer early retirement to several hundred staff in Japan, the Nikkei newspaper reported later on Friday, a move that would mark the first such headcount reduction at home in 18 years. Nissan declined to comment on the Nikkei report.
Apple Inc. (AAPL) – AI Innovation Key to Sustained Market Leadership
We recently published a list of 10 AI Stocks on Wall Street’s Radar Right Now. In this article, we are going to take a look at where Apple Inc. (NASDAQ:AAPL) stands against other AI stocks on Wall Street’s radar right now. According to a state media report, China’s President Xi Jinping has pledged “self-reliance and […]
Meta Platforms, Inc. (META): Among Billionaire David Abrams’ Stock Picks with Huge Upside Potential
We recently published a list of Billionaire David Abrams’ 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Meta Platforms, Inc. (NASDAQ:META) stands against other stock picks with huge upside potential. David Abrams founded Abrams Capital Management in 1999. Before forming the Boston-based investment firm, Abrams worked […]
Why ConocoPhillips Stock Zoomed Higher on Thursday
It topped the average analyst estimates for both revenue and profitability. ConocoPhillips (NYSE: COP) stock closed Wednesday in positive territory. On the back of a solid quarterly earnings beat, investors pushed it to a 1.4% gain, good enough to top the 0.6% bump of the S&P 500 (SNPINDEX: ^GSPC).
Why GoodRx Holdings Stock Triumphed on Thursday
The healthcare services specialist unveiled its first set of quarterly results for this year. It beat on both the top and bottom lines, and slightly increased its guidance for a profitability metric. Niche healthcare company GoodRx Holdings (NASDAQ: GDRX) was looking spry and healthy on the stock market Thursday.
Is GoodRx (GDRX) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Beyond Meat Shelves Full-Year Outlook After $7M Hit — CEO Warns Of 'Unforeseen' Economic Headwinds, But Downplays Tariff Threat
Beyond Meat Inc. (NASDAQ:BYND) missed analyst expectations in the first quarter of the ongoing fiscal year and withdrew its full-year revenue guidance, citing the ongoing economic uncertainties. However, the CEO forecasted a “relatively minimal” tariff impact on the firm. What Happened: The plant-based meat company withdrew its full-year guidance and limited its revised outlook to the second quarter net revenue expectations only. “As with many other companies, we are experiencing an elevated lev
Compared to Estimates, GoodRx (GDRX) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for GoodRx (GDRX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates
GoodRx (GDRX) delivered earnings and revenue surprises of 0% and 0.19%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: HQY